Literature DB >> 31937901

Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis.

Shiqiong Xu1,2, Tyler J Moss3, Maria Laura Rubin4, Jing Ning4, Karina Eterovic5, Hong Yu6, Renbing Jia2, Xianqun Fan2, Michael T Tetzlaff7,8, Bita Esmaeli9.   

Abstract

Ocular adnexal sebaceous carcinoma (OASeC) is an aggressive eyelid carcinoma. Analysis of molecular-genetic drivers of this disease could reveal new prognostic markers and actionable targets for treatment. To identify somatically acquired genomic mutations in OASeC and explore their associations with metastasis, whole-exome sequencing on DNA extracted from retrospectively collected tumor samples was performed. Thirty-one patients in two orbital oncology centers with OASeC were included. Sequencing results were analyzed to detect mutations and explore their possible association with metastasis. The median patient age was 64 years. A total of 1780 candidate somatic mutations were identified with median mutation rate of 1.0/Mb (range, 0.2-13.6). The five most commonly mutated genes (as determined by MutSig; q value < 0.25) were TP53 (mutated in 22 cases), ZNF750 (13 cases), RB1 (12 cases), NOTCH1 (8 cases), and PCDH15 (5 cases). Mutations in ZNF750 or NOTCH1 pathway genes were present in 24 (77%) of the 31 cases; there was a trend toward mutual exclusivity of ZNF750 and NOTCH1 mutations. All eight tumors with NOTCH1 mutations also had TP53 and/or RB1 mutations. Four of the five PCDH15 mutations and all four PCDH15 missense mutations were identified in patients with metastatic disease, including one patient with distant metastasis and three with nodal metastasis. PCDH15 was significantly associated with metastasis (P = 0.01). We identified the most commonly mutated genes in a series of OASeCs and found a previously unreported mutation in OASeC, PCDH15 mutation, that was significantly associated with metastasis. NOTCH1 mutation is an actionable mutation; clinical trials targeting this mutation are available throughout the US and could be considered for patients with metastatic NOTCH1-mutant OASeC. TP53, ZNF750, RB1, and PCDH15 mutations are most likely loss-of-function mutations and may have diagnostic and prognostic importance.

Entities:  

Year:  2020        PMID: 31937901     DOI: 10.1038/s41379-020-0454-y

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  1 in total

1.  Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis.

Authors:  Hongli Yang; Li Pan; Cong Xu; Yingxin Zhang; Keyi Li; Shuangfeng Chen; Bin Zhang; Zhijun Liu; Le-Xin Wang; Haiying Chen
Journal:  Oncol Lett       Date:  2017-09-07       Impact factor: 2.967

  1 in total
  3 in total

1.  Inferring Potential Cancer Driving Synonymous Variants.

Authors:  Zishuo Zeng; Yana Bromberg
Journal:  Genes (Basel)       Date:  2022-04-27       Impact factor: 4.141

Review 2.  Sebaceous Carcinoma Epidemiology and Genetics: Emerging Concepts and Clinical Implications for Screening, Prevention, and Treatment.

Authors:  Michael R Sargen; Gabriel J Starrett; Eric A Engels; Elizabeth K Cahoon; Margaret A Tucker; Alisa M Goldstein
Journal:  Clin Cancer Res       Date:  2020-09-09       Impact factor: 13.801

3.  Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line.

Authors:  Andrew J Rong; Ryan A Gallo; Michelle G Zhang; Ravi Doddapaneni; Anthony J Griswold; John Y Lee; Stefan Kurtenbach; Sander R Dubovy; David T Tse; Daniel Pelaez
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.